BioDelivery Sciences International, Inc.
BDSI · NASDAQ
12/31/2021 | 9/30/2021 | 6/30/2021 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $43,154 | $41,092 | $41,439 | $41,020 |
| % Growth | 5% | -0.8% | 1% | – |
| Cost of Goods Sold | $6,903 | $6,365 | $4,284 | $5,821 |
| Gross Profit | $36,251 | $34,727 | $37,155 | $35,199 |
| % Margin | 84% | 84.5% | 89.7% | 85.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $27,199 | $25,468 | $25,779 | $27,761 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$5 | $0 | -$1 | $0 |
| Operating Expenses | $27,199 | $25,468 | $25,779 | $27,761 |
| Operating Income | $9,052 | $9,259 | $11,376 | $7,438 |
| % Margin | 21% | 22.5% | 27.5% | 18.1% |
| Other Income/Exp. Net | -$1,539 | -$1,984 | -$2,000 | -$1,979 |
| Pre-Tax Income | $7,513 | $7,275 | $9,376 | $5,459 |
| Tax Expense | -$56,377 | $606 | $312 | $222 |
| Net Income | $63,890 | $6,669 | $9,064 | $5,237 |
| % Margin | 148.1% | 16.2% | 21.9% | 12.8% |
| EPS | 0.64 | 0.07 | 0.09 | 0.05 |
| % Growth | 814.3% | -22.2% | 80% | – |
| EPS Diluted | 0.61 | 0.07 | 0.09 | 0.05 |
| Weighted Avg Shares Out | 99,320 | 98,700 | 98,793 | 100,988 |
| Weighted Avg Shares Out Dil | 103,293 | 102,431 | 102,509 | 105,397 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,534 | $1,984 | $1,999 | $1,979 |
| Depreciation & Amortization | $2,060 | $1,836 | $1,768 | $1,754 |
| EBITDA | $11,112 | $11,095 | $13,144 | $9,192 |
| % Margin | 25.7% | 27% | 31.7% | 22.4% |